Skip to main content
Premium Trial:

Request an Annual Quote

Millipore, Rohm and Haas to Collaborate on Chromatography Products

NEW YORK (GenomeWeb News) - Millipore will collaborate with specialty materials firm Rohm and Haas on high-performance chromatography products for manufacturing biologic drugs, the firms announced today.
 
Millipore’s Bioprocess Division and Rohm and Haas Ion Exchange Resins plan to develop improved ion exchange chromatography products, they said. Under the terms of the alliance, Millipore will have exclusive access to new, customized chromatography media developed by the partners.
 
Jean-Paul Mangeolle, president of Millipore’s Bioprocess Division, said the partnership would take Millipore “one step closer to providing complete, integrated solutions for our biopharmaceutical customers."
 
Financial terms of the deal were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.